Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HealthCare Global EnterprisesNSE:HCG -5.76%83 PB Ratio is 7.25 as of Jul. 16, 2026, which is 53% above its 10-year median of 4.73. GuruFocus rates NSE:HCG with a GF Score™ of 83/100 and a GF Value™ of ₹580.28 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 610 Healthcare Providers & Services companies, HealthCare Global Enterprises ranks worse than 88.03% on this metric.
The historical rank and industry rank for HealthCare Global Enterprises's PB Ratio or its related term are showing as below:
NSE:HCG'
s PB Ratio Range Over the Past 10 Years
Min: 1.62 Med: 4.73 Max: 11.63
Current: 7.25
During the past 12 years, HealthCare Global Enterprises's highest PB Ratio was 11.63. The lowest was 1.62. And the median was 4.73.
NSE:HCG's PB Ratio is ranked worse than 88.03% of 610
companies
in the Healthcare Providers & Services industry
Industry Median: 2.01
vs NSE:HCG: 7.25
During the past 12 months, HealthCare Global Enterprises's average Book Value Per Share Growth Rate was 35.70% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 13.20% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 7.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 4.30% per year.
During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of HealthCare Global Enterprises was 40.40% per year. The lowest was -5.20% per year. And the median was 2.70% per year.
Back to Basics: PB Ratio
HealthCare Global Enterprises (NSE:HCG) PB Ratio Explanation
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
HealthCare Global Enterprises PB Ratio Related Terms
HealthCare Global Enterprises PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, HealthCare Global Enterprises's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthCare Global Enterprises PB Ratio vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthCare Global Enterprises's PB Ratio distribution charts can be found below:
* The bar in red indicates where HealthCare Global Enterprises's PB Ratio falls into.
HealthCare Global Enterprises PB Ratio Calculation
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
HealthCare Global Enterprises (NSE:HCG) has a PB Ratio of 7.25 as of Jul. 16, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on HealthCare Global Enterprises and its competitors. This is 53% above median its historical median of 4.73. Over the past decade, HealthCare Global Enterprises' PB Ratio has ranged from 1.62 to 11.63. According to the industry distribution chart, HealthCare Global Enterprises ranks #537 out of 610 companies in the Healthcare Providers & Services industry, placing it in the top 88%.
Is HealthCare Global Enterprises' PB Ratio too high?
HealthCare Global Enterprises' current PB Ratio of 7.25 is 53% above median its 10-year median of 4.73. Over the past 10 years, this metric has ranged from a low of 1.62 to a high of 11.63. The Healthcare Providers & Services industry median PB Ratio is 2.01. HealthCare Global Enterprises' value of 7.25 is 260.7% above this industry median. Based on the distribution chart, HealthCare Global Enterprises ranks #537 out of 610 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, HealthCare Global Enterprises has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HealthCare Global Enterprises' PB Ratio compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, HealthCare Global Enterprises ranks #537 out of 610 companies for PB Ratio. This places HealthCare Global Enterprises in the lower half of its industry. The industry median PB Ratio is 2.01. HealthCare Global Enterprises' value of 7.25 is 260.7% above this benchmark. Historically, HealthCare Global Enterprises' own PB Ratio has ranged from 1.62 to 11.63 over the past decade. While the company's 10-year median is 4.73 vs. the industry median of 2.01, HealthCare Global Enterprises has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Healthcare Providers & Services company?
The median PB Ratio among Healthcare Providers & Services companies is 2.01, based on 610 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthCare Global Enterprises's current PB Ratio of 7.25 is 260.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on HealthCare Global Enterprises and its competitors. For the Healthcare Providers & Services industry, the median PB Ratio is 2.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthCare Global Enterprises's current PB Ratio is 7.25, which is 53% above median its own 10-year median of 4.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthCare Global Enterprises stock overvalued right now?
Based on GuruFocus' analysis, HealthCare Global Enterprises (NSE:HCG) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹580.28, compared to a current price of ₹646.85 — trading 11.5% above its estimated fair value. The current PB Ratio is 7.25, which is 53% above median its 10-year median of 4.73 and 260.7% above the Healthcare Providers & Services industry median of 2.01. HealthCare Global Enterprises' overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For HealthCare Global Enterprises (NSE:HCG), the current PB Ratio is 7.25 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?
Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued.
The current stock price of ₹646.85 is trading 11.5% above its estimated GF Value™ of ₹580.28.
GuruFocus considers HealthCare Global Enterprises to be Modestly Overvalued.
Key valuation signals for NSE:HCG:
PB Ratio: 7.25 (53% above median its 10-year median of 4.73)
GF Value™: ₹580.28 vs. price of ₹646.85 (11.5% above fair value)
Industry Position: 260.7% above the Healthcare Providers & Services median (#537 of 610)
No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthCare Global Enterprises Business Description
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
83GF Score
Get the complete analysis for NSE:HCG
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:HCG has been successfully added to your 
